Whalegun
Lobbying

Spectrum Pharmaceuticals's latest lobbying report covers Q4 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Spectrum Pharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Spectrum Pharmaceuticals lobbying by quarter
Spectrum Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$0 · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Food & Drug Administration (FDA)5 reports
  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports

Firms it paid

Firm
Farragut Partners$05 quarters

Former officials lobbying for it

Former position
DYLAN MOOREIntern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)Q4 2023
EDWARD WHITFIELDU.S. Representative (21 yrs.)Q4 2023
JEFFERY C. MORTIERProf Staff on E&C Cmte LA Rep Whitfield and Intern Devin NunesQ4 2023
JEFF MACKINNONLD & LA Rep. Joe Barton (RTexas)Q4 2023
SARAH WALTERFormer Legislative Director/Chief Counsel, Sen. John BreauxQ4 2023

Lobbying reports

Filed by
24/01/22for Q4 2023Farragut PartnersUnder $5,000
23/10/20for Q3 2023Farragut PartnersUnder $5,000
23/07/20for Q2 2023Farragut PartnersUnder $5,000
23/04/20for Q1 2023Farragut PartnersUnder $5,000
23/01/20for Q4 2022Farragut PartnersUnder $5,000